{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:04:00Z","timestamp":1761919440287},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T00:00:00Z","timestamp":1303257600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0018506","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T20:59:43Z","timestamp":1303333183000},"page":"e18506","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Functional Energetics of CD4+-Cellular Immunity in Monoclonal Antibody-Associated Progressive Multifocal Leukoencephalopathy in Autoimmune Disorders"],"prefix":"10.1371","volume":"6","author":[{"given":"Aiden","family":"Haghikia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moritz","family":"Perrech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Pula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Ruhrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Potthoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert H.","family":"Brockmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Goelz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Wiendl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Lind\u00e5","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tjalf","family":"Ziemssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio E.","family":"Baranzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor-Bj\u00f6rn","family":"K\u00e4ll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dietmar","family":"Bengel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Gold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,4,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1212\/01.wnl.0000257832.38943.2b","article-title":"Reactivation of JC virus and development of PML in patients with multiple sclerosis.","volume":"68","author":"K Khalili","year":"2007","journal-title":"Neurology"},{"key":"ref2","first-page":"977","article-title":"Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy.","volume":"22","author":"MM Thurnher","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/jnen\/62.5.429","article-title":"The changing pattern of HIV neuropathology in the HAART era.","volume":"62","author":"F Gray","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJMp0906248","article-title":"Reemergence of PML in Natalizumab-Treated Patients \u2013 New Cases, Same Concerns.","volume":"361","author":"EO Major","year":"2009","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S1470-2045(09)70161-5","article-title":"Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.","volume":"10","author":"KR Carson","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1182\/blood-2008-10-186999","article-title":"Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project.","volume":"113","author":"KR Carson","year":"2009","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases.","volume":"9","author":"DB Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/brain\/awh215","article-title":"A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.","volume":"127","author":"RA Du Pasquier","year":"2004","journal-title":"Brain"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMoa0810257","article-title":"Treatment of severe Progressive Multifocal Leukoencephalopathy associated with natalizumab monotherapy.","volume":"361","author":"W Wenning","year":"2009","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMoa0810316","article-title":"Progressive Multifocal Leukoencephalopathy after treatment with Natalizumab as monotherapy in a Patient with Multiple Sclerosis.","volume":"361","author":"H Lind\u00e5","year":"2009","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/13550280290167894","article-title":"Overview of the cellular immunity against JC virus in progressive multifocal leukoencephalopathy.","volume":"8","author":"IJ Koralnik","year":"2002","journal-title":"J Neurovirol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00002030-200307040-00004","article-title":"Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.","volume":"17","author":"J Gasnault","year":"2003","journal-title":"AIDS"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1097\/00002030-200307040-00017","article-title":"JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML.","volume":"17","author":"JR Berger","year":"2003","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1084\/jem.188.12.2199","article-title":"The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses.","volume":"188","author":"SA Kalams","year":"1998","journal-title":"J Exp Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4049\/jimmunol.168.1.499","article-title":"Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope.","volume":"168","author":"IJ Koralnik","year":"2002","journal-title":"J Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"11918","DOI":"10.1128\/JVI.77.22.11918-11926.2003","article-title":"Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1(p36) in patients with proven or possible progressive multifocal leukoencephalopathy.","volume":"77","author":"RA Du Pasquier","year":"2003","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/nri1710","article-title":"Fuel feeds function: energy metabolism and the T-cell response.","volume":"5","author":"CJ Fox","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1128\/CDLI.7.2.307-311.2000","article-title":"Measurement of T-lymphocyte responses in whole-blood cultures using newly synthesized DNA and ATP.","volume":"7","author":"PR Sottong","year":"2007","journal-title":"Clin Diagn Lab Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/MOT.0b013e32832c5999","article-title":"Diagnostic value of T-cell monitoring assays in kidney transplantation.","volume":"14","author":"P Nickel","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1309\/23YGPB1E758ECCFP","article-title":"Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation.","volume":"129","author":"I Batal","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(98)00266-5","article-title":"Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy.","volume":"95","author":"G De Luca","year":"1999","journal-title":"J Neuroimmunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1001\/archneur.63.7.930","article-title":"Plasma exchange in neuroimmunological disorders: Part 1: Rationale and treatment of inflammatory central nervous system disorders.","volume":"63","author":"HC Lehmann","year":"2006","journal-title":"Arch Neurol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archneur.63.8.1066","article-title":"Plasma exchange in neuroimmunological disorders: part 2. Treatment of neuromuscular disorders.","volume":"63","author":"HC Lehmann","year":"2006","journal-title":"Arch Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa044396","article-title":"Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.","volume":"354","author":"RA Rudick","year":"2006","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/j.1742-4658.2005.04586.x","article-title":"Characterization of depolarization and repolarization phases of mitochondrial membrane potential fluctuations induced by tetramethylrhodamine methyl ester photoactivation.","volume":"272","author":"AM Falchi","year":"2005","journal-title":"FEBS J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","article-title":"Anti-JC Virus Antibodies: Implications for PML Risk Stratification.","volume":"68","author":"L Gorelik","year":"2010","journal-title":"Ann Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","article-title":"Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis.","volume":"353","author":"BK Kleinschmidt-DeMasters","year":"2005","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","article-title":"Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.","volume":"353","author":"A Langer-Gould","year":"2005","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","article-title":"Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease.","volume":"353","author":"G Van Assche","year":"2005","journal-title":"N Engl J Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000341766.59028.9d","article-title":"Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function.","volume":"72","author":"BO Khatri","year":"2009","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-5728(90)90048-R","article-title":"Increased proliferation of blood mononuclear cells after plasmapheresis treatment of patients with demyelinating disease.","volume":"30","author":"PC Dau","year":"1990","journal-title":"J Neuroimmunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1046\/j.1365-2567.1997.00351.x","article-title":"Anti-alpha 4 integrin antibody induces apoptosis in murine thymocytes and staphylococcal enterotoxin B-activated lymph node T cells.","volume":"92","author":"EZ Tchilian","year":"1997","journal-title":"Immunology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s004010100444","article-title":"Blockade of signaling via the very late antigen (VLA-4) and its counterligand vascular cell adhesion molecule-1 (VCAM-1) causes increased T cell apoptosis in experimental autoimmune neuritis.","volume":"103","author":"VI Leussink","year":"2002","journal-title":"Acta Neuropathol"},{"key":"ref34"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/archneur.65.12.noc80051","article-title":"Decrease in the Numbers of Dendritic Cells and CD4+ T Cells in Cerebral Perivascular Spaces Due to Natalizumab.","volume":"65","author":"MD Martin","year":"2008","journal-title":"Arch Neurol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1001\/archneurol.2009.157","article-title":"Depletion of B lymphocytes from cerebral perivascular spaces by rituximab.","volume":"66","author":"MD Martin","year":"2009","journal-title":"Arch Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1371\/journal.pone.0002028","article-title":"Reactivation of human herpesvirus-6 in natalizumab treated multiple sclerosis patients.","volume":"3","author":"K Yao","year":"2008","journal-title":"PLoS ONE"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/ard.2006.058404","article-title":"Natalizumab and progressive multifocal leucoencephalopathy.","volume":"65","author":"JR Berger","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archneurol.2009.31","article-title":"Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study.","volume":"66","author":"A Boster","year":"2009","journal-title":"Arch Neurol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jneuroim.2007.04.006","article-title":"Expert opinion: guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies.","volume":"187","author":"R Gold","year":"2007","journal-title":"J Neuroimmunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-0012.2003.00013.x","article-title":"Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management.","volume":"17","author":"R Kowalski","year":"2003","journal-title":"Clin Transplant"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0018506","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T12:31:49Z","timestamp":1592483509000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0018506"}},"subtitle":[],"editor":[{"given":"Mehrdad","family":"Matloubian","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,20]]},"references-count":41,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0018506","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,20]]}}}